drugset

drugset / Trial / NCT04582097

Ramipril in Pediatric Patients on Hemodialysis

NCT04582097 ↗

Phase 2/3 Completed 135 enrolled Ain Shams University

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the study is to evaluate the effect of Ramipril in pediatric patients on regular hemodilaysis

Timeline

Start: 2018-12-01
Primary completion: 2019-03-01
Completion: 2020-02-28

Publications

Ateya AM, El Hakim I, Shahin SM, El Borolossy R, Kreutz R, Sabri NA. Effects of Ramipril on Biomarkers of Endothelial Dysfunction and Inflammation in Hypertensive Children on Maintenance Hemodialysis: the SEARCH Randomized Placebo-Controlled Trial. Hypertension. 2022 Aug;79(8):1856-1865. doi: 10.1161/HYPERTENSIONAHA.122.19312. Epub 2022 Jun 10.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ramipril	Small molecule	2.5 mg	Oral

Indications

No indication recorded.